ETA-DOC-0004·Compound index·Rev 1·Methodology v0.1Provisional — reviewer not yet appointed
compound index · I, page 1 of 3 · methodology v0.1 · reviewer not yet appointed
Compound index · I ETA-DOC-0004

Compound index — I

490 substances begin with I. 4 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, I omega kids®/Pufan 3… – Influenza A Virus….

US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
I omega kids®/Pufan 3 kids® containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) EU-CLAIM Not yet graded
EU claims 0 authorised / 7 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Calming”Non-authorisedArt.14(1)(b)EFSA opinion
“Provide serenity and room for a beneficial development of the child”Non-authorisedArt.14(1)(b)EFSA opinion
“Helps to promote the thinking capacity”Non-authorisedArt.14(1)(b)EFSA opinion
“Help to promote concentration”Non-authorisedArt.14(1)(b)EFSA opinion
“Help to support vision”Non-authorisedArt.14(1)(b)EFSA opinion
“Help to support mental development”Non-authorisedArt.14(1)(b)EFSA opinion
“Help to support the learning ability”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007586
ibafloxacin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQJ01MA96
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007587
IBalance – killed heat treated microorganisms EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-007588
Ibalizumab EU-MEDUS-DRUG Not yet graded
EU medicine: WithdrawnUS: bla
Class as recordedAntibodies; CD4-directed Antibody Interactions [MoA]; CD4-directed Blocking Antibody [EPC]; HIV 1 Post-attachment Fusion Inhibitors [MoA]
Market presence4 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007589
Ibalizumab-Uiyk US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007590
Ibandronate Sodium US-DRUG Not yet graded
US: anda
Class as recordedBisphosphonate [EPC]; Diphosphonates [CS]
Earliest US approval2003
Market presence16 US product listings · 20 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007591
ibandronic acid EU-MED Not yet graded
EU medicine: Application withdrawn, Authorised
Class as recordedM05BA06
Market presence9 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007592
Iberis amara CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007593
Iberis Amara Seed US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007594
Ibogaine US-CSA Not yet graded
CSA Schedule I
Class as recordedDEA: hallucinogen / synthetic cannabinoid
DEA other namesConstituent of "Tabernanthe iboga" plant
Recorded fromUS-CSA — 1 of 7 registers
Etalyn identifierETA-C-007595
Ibrexafungerp Citrate US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007596
Ibritumomab Tiuxetan EU-MEDUS-DRUG Not yet graded
EU medicine: Lapsed
Class as recordedV10XX02
Earliest US approval2002
Market presence1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007597
Ibrutinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; L01EL01; Protein Kinase Inhibitors [MoA]
Earliest US approval2013
Market presence34 US product listings · 10 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007598
Ibuprofen EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic alpha1-Agonists [MoA]; Allergens [CS]; Anti-Inflammatory Agents
Earliest US approval1974
Market presence1,480 US product listings · 270 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007599
Ibuprofen Arginine US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007600
Ibuprofen Lysine US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval2006
Market presence6 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007601
Ibutamoren ETALYNUS-DRUG D/supportedband 6
US: bulk ingredient
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007602
Ibutilide Fumarate US-DRUG Not yet graded
US: anda
Class as recordedAntiarrhythmic [EPC]
Earliest US approval1995
Market presence5 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007603
icatibant EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedB06AC02; Bradykinin B2 Receptor Antagonist [EPC]; Bradykinin B2 Receptor Antagonists [MoA]
Earliest US approval2011
Market presence22 US product listings · 11 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007604
Ichthammol US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Actively Acquired Immunity [PE]; Alkalinizing Activity [MoA]; Allergens [CS]
Market presence13 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007605
Ichthyolum CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007606
Icodextrin US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBlood Coagulation Factor [EPC]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Cations
Earliest US approval2002
Market presence6 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007607
Icosapent US-DRUG Not yet graded
US: drug for further processing
Class as recordedAnalogs/Derivatives [Chemical/Ingredient]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007608
Icosapent Ethyl EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedC10AX
Earliest US approval2012
Market presence73 US product listings · 13 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007609
Icotrokinra EU-MEDUS-DRUG Not yet graded
EU medicine: OpinionUS: bulk ingredient
Earliest US approval2026
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007610
Idarubicin Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedAnthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Topoisomerase Inhibitors [MoA]
Earliest US approval1990
Market presence15 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007611
Idarucizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; Humanized Monoclonal Antibody Fragment [EPC]; Humanized [CS]; Monoclonal
Earliest US approval2015
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007612
Idebenone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient
Class as recordedN06BX13
Market presence2 US product listings · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007613
Idecabtagene Vicleucel EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedL01
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007614
Idelalisib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCytochrome P450 3A Inhibitors [MoA]; Kinase Inhibitor [EPC]; Kinase Inhibitors [MoA]; L01XX47
Earliest US approval2014
Market presence6 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007615
Idoxuridine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1963
Market presence1 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007616
Idraparinux Sodium US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007617
Idursulfase EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedA16AB09; Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]; alpha-Glucosidases [CS]
Earliest US approval2006
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007618
Ifosfamide US-DRUG Not yet graded
US: anda
Class as recordedAlkylating Activity [MoA]; Alkylating Drug [EPC]
Earliest US approval1987
Market presence11 US product listings · 7 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007619
IGF-1 LR3 ETALYN E/insufficientband 6
also: Long R3 IGF-1
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-007620
Ignatia CA-NHP Not yet graded
CA licensed ingredient
Market presence46 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007621
Ignatia amara CA-NHP Not yet graded
CA licensed ingredient
Market presence123 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007622
igovomab EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedV09IB03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007623
Ilex aquifolium CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007624
Ilex Aquifolium Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Blood Coagulation Factor [EPC]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007625
Ilex Aquifolium Fruiting TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007626
Ilex Aquifolium Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007627
Ilex Aquifolium Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007628
Ilex aquifolium-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007629
Ilex asprella CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
Market presence4 Canadian licensed products
Parts in scopeRoot
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-007630
Ilex chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007631
Ilex cornuta CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007632
Ilex guayusa CA-NHPEU-NOVEL Not yet graded
Novel, not yet authorisedCA licensed ingredient
also: Ilex utilis Moldenke
Market presence13 Canadian licensed products
Parts in scopeAll parts of the tree; Aqueous extract of dried leaves
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-007633
Ilex kudingcha CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007634
Ilex paraguariensis CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
Market presence327 Canadian licensed products
Parts in scopeLeaves; Non concentrated aqueous infusion (leaves)
Recorded fromCA-NHP, EU-NOVEL — 2 of 7 registers
Etalyn identifierETA-C-007635
Ilex pubescens CA-NHP Not yet graded
CA licensed ingredient
Market presence32 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007636
Ilex rotunda CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007637
Illicium anisatum CA-NHP Not yet graded
CA licensed ingredient
Market presence23 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007638
Illicium difengpi CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007639
Illicium verum CA-NHP Not yet graded
CA licensed ingredient
Market presence31 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007640
Illicium Verum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007641
Iloperidone EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, RefusedUS: anda
Class as recordedAtypical Antipsychotic [EPC]; N05AX14
Earliest US approval2009
Market presence26 US product listings · 5 FDA applications · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007642
Iloprost EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedB01AC11; Prostacycline [EPC]; Prostaglandins I [CS]
Earliest US approval2004
Market presence4 US product listings · 3 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007643
Ilunocitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: drug for further processing
Market presence4 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007644
Imatinib EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedBcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2001
Market presence70 US product listings · 19 FDA applications · 6 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007645
imatinib mesilate EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL01EA01; L01XE01
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007646
Imciromab Pentetate US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007647
imdevimab EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ06BD07
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007648
Imeglimin US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007649
Imepitoin EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence3 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007650
imetelstat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XX80; Oligonucleotide Telomerase Inhibitor [EPC]; Oligonucleotide Telomerase Inhibitors [MoA]
Earliest US approval2024
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007651
Imidacloprid EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Market presence2 US product listings · 2 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007652
Imidocarb Dipropionate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007653
Imidurea US-DRUG Not yet graded
US: otc monograph final
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007654
Imiglucerase EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedA16AB02; Glucosylceramidase [CS]; Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
Earliest US approval1994
Market presence3 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007655
Imipenem EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCarbapenems [CS]; Dipeptidase Inhibitors [MoA]; J01DH56; Penem Antibacterial [EPC]
Earliest US approval1985
Market presence13 US product listings · 8 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007656
Imipramine Pamoate US-DRUG Not yet graded
US: anda
Class as recordedTricyclic Antidepressant [EPC]
Earliest US approval1959
Market presence45 US product listings · 44 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007657
Imiquimod EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedD06BB10; Increased Cytokine Activity [PE]; Increased Cytokine Production [PE]; Interferon Inducers [MoA]
Earliest US approval1997
Market presence25 US product listings · 12 FDA applications · 3 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007658
imlifidase EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL04AA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007659
Imlunestrant US-DRUG Not yet graded
US: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]
Earliest US approval2025
Market presence2 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007660
imlunestrant tosilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL02BA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007661
Immune Balance Drink, containing vitamin C, green tea extract, grape skin extract, grape seed extract, and shiitake mushroom extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“The Immune Balance Drink activates body's defence”Non-authorisedArt.13(5)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007662
Immunofortis®, a mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Immunofortis® to naturally strengthen your baby’s immune system”Non-authorisedArt.14(1)(b)EFSA opinion
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-007663
Impatiens balsamina CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007664
Impatiens glandulifera CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007665
Impatiens Glandulifera Flower US-DRUG Not yet graded
US: drug for further processing
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antimalarial [EPC]
Market presence81 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007666
Impatiens Glandulifera Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007667
Impatiens glandulifera-flos CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007668
Imperata cylindrica CA-NHP Not yet graded
CA licensed ingredient
Market presence58 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007669
Imperata Cylindrica Root US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007670
Imperatoria Ostruthia Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007671
in-vitro expanded EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedM09AX02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007672
inactivated EU-MED Not yet graded
EU medicine: Authorised, Expired
Class as recordedJ07BA02; J07BB01; J07BB02; QI06AH
Market presence23 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007673
inactivated avian infectious bronchitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007675
inactivated avian reovirus strain ARV-1 EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007676
inactivated avian reovirus strain ARV-4 EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007677
inactivated bluetongue virus EU-MED Not yet graded
EU medicine: Authorised, Withdrawn
Class as recordedQI02AA08; QI04AA02
Market presence8 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007678
inactivated Bordetella bronchiseptica EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007679
inactivated Bordetella bronchiseptica cells EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007680
inactivated Bordetella pertussis EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07CA10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007681
inactivated chimaeric flavivirus strain YF-WN EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007682
inactivated containing antigen of strain A/California/07/2009 (H1N1)v EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07BB01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007683
inactivated Coxiella burnetii vaccine EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007684
inactivated feline calicivirosis antigens (FCV 431 and G1 strains) EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedQI06AH
Market presence5 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007685
inactivated feline calicivirus EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007686
inactivated feline Chlamydophila felis EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007687
inactivated feline leukaemia virus EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007688
inactivated feline panleukopenia virus EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007689
inactivated feline rhinotracheitis virus EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007690
inactivated fimbrial adhesins of Escherichia coli EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007691
Inactivated fimbrial adhesins of Escherichia coli F4ab EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007692
Inactivated fimbrial adhesins of Escherichia coli F4ac EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007693
Inactivated fimbrial adhesins of Escherichia coli F5 EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007694
Inactivated fimbrial adhesins of Escherichia coli F6 EU-MED Not yet graded
EU medicine: Withdrawn
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007695
inactivated foot-and-mouth disease virus strains: O1 Manisa ≥ 6 PD50* EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI02AA04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007696
inactivated IBR virus EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI02AA03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007697
inactivated immunological veterinary medicinal product containing Leptospira interrogans EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007698
inactivated infectious bursal disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007699
inactivated influenza-A virus EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI09AA03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007700
inactivated influenza-A virus / swine EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007701
Inactivated Leptospira strains: L. interrogans serogroup Canicola serovar Portland-vere (strain Ca-12-000) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007702
Inactivated Mycoplasma hyopneumoniae EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007703
inactivated porcine circovirus type 2 (PCV2) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007704
inactivated rabbit haemorrhagic disease type 2 virus (RHDV2) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007705
inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2 ORF2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007706
inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2a open reading frame 2 (ORF2) protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007707
inactivated recombinant chimeric porcine circovirus type 1 containing the porcine circovirus type 2b ORF2 protein EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007708
inactivated Schmallenberg virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007709
Inactivated Type 1 Poliovirus (Mahoney) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07CA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007710
Inactivated Type 3 Poliovirus (Saukett) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ07CA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007711
inactivated vaccine against yersiniosis EU-MED Not yet graded
EU medicine: Authorised
Class as recordedQI10AB04
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007712
inactivated West Nile virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007713
inactivated whole avian influenza virus antigen of H5 subtype (strain H5N6, A/duck/Potsdam/2243/84) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI01AA23
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007714
inactivated whole avian influenza virus antigen of H5N2 subtype (strain A/duck/Potsdam/1402/86) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007715
inactivated whole avian influenza virus antigen of H7N1 subtype (strain, A/CK/Italy/473/99) EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI01AA23
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007716
inactivated whole cell suspension of Ornithobacterium rhinotracheale serotype A EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQI01AB07
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007717
inactivated: A/Viet Nam/1194/2004 (H5N1) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ07BB02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007674
Inamrinone Lactate US-DRUG Not yet graded
Earliest US approval1984
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007718
Inavolisib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedKinase Inhibitor [EPC]; Phosphoinositide 3-Kinase alpha Inhibitors [MoA]
Earliest US approval2024
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007719
Inca Peanut Protein CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007720
Incised Notopterygium Rhizome OR Root (notopterygium Franchetii) US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007721
Inclisiran EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedC10AX
Earliest US approval2021
Market presence5 US product listings · 1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007722
incobotulinumtoxinA US-DRUG Not yet graded
Earliest US approval2010
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007723
Indacaterol EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedR03AC18; R03AK; R03AL; R03AL04
Earliest US approval2011
Market presence2 US product listings · 2 FDA applications · 4 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007724
Indapamide US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]
Earliest US approval1983
Market presence27 US product listings · 11 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007725
Indecainide Hydrochloride US-DRUG Not yet graded
Earliest US approval1989
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007726
Indian Frankincense US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Amino Acids; Aromatic Amino Acid [EPC]; Aromatic [CS]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007727
Indian Frankincense Boswellic acids-Phosphatidylcholine complex CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007728
Indian tinospora CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007729
Indigo CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Market presence10 US product listings · 10 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007730
Indigo Naturalis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007731
Indigofera tinctoria CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007732
Indigotindisulfonate Sodium US-DRUG Not yet graded
US: bulk ingredient
Class as recordedDiagnostic Dye [EPC]; Dyes [MoA]
Earliest US approval2022
Market presence5 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007733
Indinavir Sulfate US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007734
indinavir sulfate ethanolate EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedJ05AE02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007735
Indium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence29 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007736
Indium Cation IN-111 US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007737
Indium IN-111 Chloride US-DRUG Not yet graded
Earliest US approval1992
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007738
Indium IN-111 Oxyquinoline US-DRUG Not yet graded
US: anda
Earliest US approval1985
Market presence2 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007739
Indium IN-111 Pentetate Disodium US-DRUG Not yet graded
US: nda
Earliest US approval1982
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007740
Indium IN-111 Pentetreotide KIT US-DRUG Not yet graded
Earliest US approval1994
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007741
Indium metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence18 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007742
Indocyanine Green US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1959
Market presence8 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007743
Indocyanine Green Acid Form US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007744
Indole CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: drug for further processing
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Amino Acids; Anti-coagulant [EPC]
Market presence38 US product listings · 3 Canadian licensed products
Recorded fromCA-NHP, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007745
Indole-3-Carbinol CA-NHPEU-CLAIMEU-NOVELUS-DRUG Not yet graded
Novel, not yet authorisedEU claims 0 authorised / 2 refusedCA licensed ingredientUS: unapproved homeopathic
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Catecholamine [EPC]
Market presence2 US product listings · 2 Canadian licensed products
Parts in scopeSubstance
Claims examined by the EU — wording reproduced, not Etalyn’s.
Claim as submittedRulingBasisOpinion
“Indole-3-carbinol supports the defence ability of female reproductive organs (ovaria, uterus, breasts). Indole-3-carbinol helps to support the healthy development and fission of soft tissues of male and female reproductive organs, stomach, colon and larynx.”Non-authorisedArt.13(1)EFSA opinion
“Indole-3-carbinol supports the regular fenotype of cells and positively affects the induction of apoptosis of damaged cells”Non-authorisedArt.13(1)EFSA opinion
Recorded fromCA-NHP, EU-CLAIM, EU-NOVEL, US-DRUG — 4 of 7 registers
Etalyn identifierETA-C-007746
Indolo(2',3':3,4)pyrido(2,1-b)quinazolin-5(7H)-one, 8,13,13b,14-tetrahydro-14-methyl-, (13bS)- CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007747
Indolum CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-007748
Indomethacin US-DRUG Not yet graded
US: anda
Class as recordedAnti-Inflammatory Agents; Cyclooxygenase Inhibitors [MoA]; Non-Steroidal [CS]; Nonsteroidal Anti-inflammatory Drug [EPC]
Earliest US approval1965
Market presence94 US product listings · 75 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007749
indoxacarb EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQP53AC54
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007750
Indoximod US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007751
Inebilizumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedCD19-directed Antibody Interactions [MoA]; CD19-directed Cytolytic Antibody [EPC]; L04AA
Market presence1 US product listings · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007752
Inebilizumab-Cdon US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007753
infectious bovine rhinotracheitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007754
infectious bronchitis virus EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007755
Infectious bursal disease virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-007756
Infigratinib Phosphate EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn
Class as recordedL01E
Earliest US approval2021
Market presence1 FDA applications · 1 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007757
Infliximab EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bla
Class as recordedL04AB02; Tumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Earliest US approval1998
Market presence10 US product listings · 1 FDA applications · 7 EU medicines
Recorded fromEU-MED, US-DRUG — 2 of 7 registers
Etalyn identifierETA-C-007758
Infliximab-Abda US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2017
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007759
Infliximab-Axxq US-DRUG Not yet graded
Earliest US approval2019
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007760
Infliximab-Dyyb US-DRUG Not yet graded
US: bla
Class as recordedTumor Necrosis Factor Blocker [EPC]; Tumor Necrosis Factor Receptor Blocking Activity [MoA]
Earliest US approval2016
Market presence8 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007761
Infliximab-Qbtx US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2017
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007762
Influenza A Virus US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bee Venoms [CS]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]
Market presence39 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007763
Influenza A Virus A/brisbane/10/2010 (H1N1) Hemagglutinin Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007764
Influenza A Virus A/brisbane/10/2010 (H1N1) Neuraminidase Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Analogs/Derivatives [Chemical/Ingredient]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007765
Influenza A Virus A/brisbane/59/2007 (H1N1) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007766
Influenza A Virus A/croatia/10136rv/2023 X-425A (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence12 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007767
Influenza A Virus A/darwin/1369/2025 (H3N2) Live (attenuated) Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007768
Influenza A Virus A/darwin/1415/2025 (H3N2) Recombinant Hemagglutinin Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007769
Influenza A Virus A/darwin/6/2021 (H3N2) Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007771
Influenza A Virus A/darwin/6/2021 IVR-227 (H3N2) Antigen (propiolactone Inactivated) US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007770
Influenza A Virus A/darwin/9/2021 IVR-228 (H3N2) Antigen (uv, Formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007772
Influenza A Virus A/darwin/9/2021 IVR-228 (H3N2) Hemagglutinin Antigen (uv, Formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence16 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007773
Influenza A Virus A/darwin/9/2021 SAN-010 (H3N2) Hemagglutinin Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007774
Influenza A Virus A/georgia/12/2022 CVR-167 (H1N1) Antigen (mdck Cell Derived, Propiolactone Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007775
Influenza A Virus A/guangdong-Maonan/swl1536/2019 Cnic-1909 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007776
Influenza A Virus A/hong Kong/2671/2019 IVR-208 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Actively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007777
Influenza A Virus A/michigan/105/2025 IVR-285 (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007778
Influenza A Virus A/michigan/105/2025 SAN 049A (H3N2) Antigen (uv, Formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007779
Influenza A Virus A/michigan/105/2025 SAN-049A (H3N2) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007780
Influenza A Virus A/missouri/11/2025 (H1N1) Recombinant Hemagglutinin Antigen US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007782
Influenza A Virus A/missouri/11/2025 IVR-279 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: bla
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007781
Influenza A Virus A/north Carolina/04/2016 (H3N2) Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007783
Influenza A Virus A/singapore/gp1908/2015 IVR-180 (H1N1) Antigen (formaldehyde Inactivated) US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007784
Influenza A Virus A/singapore/gp1908/2015 IVR-180 (H1N1) Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-007785